First Drug Approved in New Class of Non-Opioid Pain Medicines
Dr. Tesha Monteith discusses Journavx (suzetrigine), a new medication for pain management. Show references
Read the full articleYou might also wanna read
FDA Approves First Non-Opioid Pain Reliever: Journavx by Vertex Pharmaceuticals
Journavx was approved this year. Why did it take so long to develop?
worksinprogress.news·1y agoFDA Approves First New Class of Non-Opioid Pain Drug, Offering Hope for Millions Suffering from Acute Pain
In its first major decision under the newly inaugurated Trump administration, the FDA has approved a non-opioid pain medication. As healthca
Suzetrigine aims to deliver non-addictive, non-opioid pain relief
Interview with Vandana Sharma, MD
Efficacy and Safety Between Tegileridine and Sufentanil in Laparoscopic Surgery Patients at High Risk of Postoperative Nausea and Vomiting
Conditions : Postoperative Nausea and Vomiting (PONV); Enhanced Recovery After Surgery; Laparoscopic Surgery Interventions : Drug: analgesic
Efficacy of Non-opioid Drugs in Addition to Opioid Therapy for Cancer Pain Management
Conditions : Cancer Pain; Cancer Palliative Care Interventions : Drug: Metamizole; Drug: Ibuprofen; Other: Placebo Sponsors : University Hos
Intranasal Zavegepant for the acute treatment of migraine in adults: A review of randomized clinical trials
Migraine is a highly prevalent chronic neurological disorder and one of the leading causes of disability worldwide. Among recent therapeutic
Comments
Sign in to join the conversation.
No comments yet. Be the first.